Given a serum iron of 34 µg/dL, total iron‑binding capacity of 373 µg/dL, and transferrin saturation of 9 %, does the patient require an intravenous iron infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does This Patient Need an Iron Infusion?

Yes, this patient has severe iron deficiency (transferrin saturation of 9%) and should receive intravenous iron therapy, particularly if oral iron has failed, is not tolerated, or if there are underlying conditions affecting iron absorption.

Understanding the Laboratory Values

Your patient's labs demonstrate:

  • Transferrin saturation: 9% (critically low; normal >20%)
  • TIBC: 373 µg/dL (elevated, suggesting iron deficiency)
  • Serum iron: 34 µg/dL (low)

This pattern is diagnostic of absolute iron deficiency. The transferrin saturation of 9% is well below the 20% threshold used across multiple guidelines to define iron deficiency 1.

When IV Iron is Indicated

According to the 2024 AGA guidelines, intravenous iron should be used if:

  • The patient does not tolerate oral iron
  • Ferritin levels do not improve with a trial of oral iron
  • The patient has a condition where oral iron is unlikely to be absorbed 2

The 2021 British Society of Gastroenterology guidelines specify that transferrin saturation <20% indicates absolute iron deficiency requiring treatment 1. Your patient at 9% is significantly below this threshold.

Clinical Context Matters

The decision depends on the underlying condition:

If the patient has Chronic Heart Failure:

  • IV iron is strongly preferred over oral iron
  • Transferrin saturation <20% meets criteria for IV iron therapy
  • IV iron has demonstrated prognostic benefit in meta-analyses
  • Oral iron should be avoided as it may be poorly absorbed due to gut edema and causes frequent side effects 1

If the patient has Chronic Kidney Disease:

  • Transferrin saturation ≤20% defines absolute iron deficiency
  • IV iron is required if oral iron is not tolerated or ineffective
  • IV iron is mandatory if dialysis has commenced 1

If the patient has Inflammatory Bowel Disease with active inflammation:

  • IV iron should be given when there is active inflammation compromising absorption
  • Transferrin saturation <20% with active disease favors IV therapy 1, 2

If the patient is otherwise healthy:

  • Start with oral iron supplementation (once daily or every other day)
  • Add vitamin C to improve absorption
  • Switch to IV iron if oral iron is not tolerated or ineffective after a trial period 2

Practical Approach

Step 1: Determine if there are conditions affecting iron absorption:

  • Active inflammation (IBD, chronic disease)
  • Malabsorption (celiac disease, bariatric surgery)
  • Chronic kidney disease
  • Heart failure
  • Ongoing blood loss

Step 2: If any of the above conditions exist, proceed directly to IV iron given the severely low transferrin saturation of 9%.

Step 3: If none of these conditions exist, you may trial oral iron first, but the extremely low transferrin saturation (9%) suggests this patient likely needs IV iron regardless.

Important Caveats

  • Don't rely solely on transferrin saturation in CKD patients: Protein-energy wasting may lower TIBC, leading to falsely normal TSAT even when iron deficiency is present 3
  • Check ferritin levels: While not provided in your question, ferritin helps distinguish absolute from functional iron deficiency
  • All IV iron formulations are safe: True anaphylaxis is very rare; most reactions are complement activation-related pseudo-allergy (infusion reactions) 2
  • Prefer single or two-dose IV iron regimens over multiple infusions for patient convenience 2

Bottom Line

With a transferrin saturation of 9%, this patient has severe iron deficiency. IV iron is likely necessary, especially if there are any underlying conditions affecting absorption, tolerance issues with oral iron, or if this represents a failure of oral iron therapy. Even in otherwise healthy patients, this degree of iron deficiency may warrant IV therapy for faster repletion.

Related Questions

When should iron infusions be considered for a patient with total iron‑binding capacity 445 µg/dL, serum iron 32 µg/dL, transferrin saturation 7 % and ferritin 11 ng/mL?
With a serum iron of 39 µg/dL and a transferrin saturation of 9 %, what are the recommended management steps?
In a 64-year-old woman with ferritin 306 ng/mL, hemoglobin 12.9 g/dL, serum iron 54 µg/dL, TIBC 250 µg/dL, iron saturation 22 % while taking ferrous sulfate (325 mg) daily, and an isolated serum chloride of 107 mmol/L, should I stop the iron supplement and how should I address the elevated chloride?
What is the diagnosis and recommended management for a patient with low serum iron, low ferritin, elevated transferrin, elevated total iron‑binding capacity (TIBC), elevated C‑reactive protein (CRP), and normal vitamin B12?
Is an intravenous iron infusion indicated for a ferritin level of 29.8 ng/mL?
What metabolic disorders should be considered in a 4‑month‑old infant with megacolon, recurrent hypoglycemia, transfusion‑dependent anemia, thrombocytopenia, acute renal failure on dialysis, and ongoing sepsis who has a normal chest X‑ray and no hepatosplenomegaly, and what initial management is recommended?
Can latanoprost be taken twice daily?
How should hypotension be managed in an 88-year-old woman with hypertension on olmesartan (angiotensin II receptor blocker), hydrochlorothiazide (thiazide diuretic), and labetalol (beta‑blocker/alpha‑blocker), who recently completed a 5‑day prednisone course for a right‑ear infection and now presents with worsening headache, ear burning, and a blood pressure of 85/45 mm Hg?
What are the indications for revascularization of the left main coronary artery and the left anterior descending artery?
In an infant who has stopped dialysis and is not experiencing hypoglycemia but has markedly elevated triglycerides, what is the appropriate management?
What other name is used for Acute Respiratory Distress Syndrome (ARDS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.